Is there any published or ongoing meta‑analysis that matches the title and scope of my planned network meta‑analysis of colorectal anastomosis techniques assessing anastomotic leak rates and hospital length of stay while excluding adhesion outcomes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Existing and Ongoing Meta-Analyses on Colorectal Anastomotic Techniques

Yes, multiple meta-analyses already exist that directly address colorectal anastomosis techniques, anastomotic leak rates, and hospital length of stay—the exact scope of your planned network meta-analysis.

Published Meta-Analyses Matching Your Scope

Most Recent and Directly Relevant

The evidence reveals several published meta-analyses that overlap substantially with your planned study:

For Crohn's Disease Population:

  • A 2024 ECCO guideline 1 references a network meta-analysis of 11 trials with 1,113 patients comparing multiple anastomotic configurations (stapled side-to-side, hand-sewn end-to-end, and others). This study specifically evaluated anastomotic leak rates, overall complications, clinical recurrence, reoperation rates, mortality, and length of hospital stay—nearly identical to your planned outcomes.

  • An earlier meta-analysis 1 compared 396 stapled side-to-side anastomoses with 425 hand-sewn end-to-end anastomoses, examining overall postoperative complications, anastomotic leak, recurrence, and reoperation for recurrence.

  • A 2007 meta-analysis 2 of 8 studies (712 anastomoses) compared end-to-end versus other configurations in Crohn's disease, specifically reporting on anastomotic leak rates and postoperative hospital stay.

For General Colorectal Surgery:

  • A 2026 systematic review and Bayesian network meta-analysis 3 compared multiple anastomotic techniques after total mesorectal excision in rectal cancer, evaluating anastomotic leakage as the primary outcome and overall postoperative morbidity—directly matching your planned outcomes.

  • Another 2026 systematic review and meta-analysis 4 compared stapled versus hand-sewn colorectal anastomoses across observational cohorts, specifically assessing anastomotic leak, surgical site infection, length of stay, and mortality—the exact outcomes you plan to evaluate.

  • A 2026 meta-analysis 5 of 14 studies (3,046 patients) compared single-stapling versus double-stapling techniques for rectal anastomosis, with anastomotic leak as the primary outcome and length of hospital stay as a secondary outcome.

For Emergency/Trauma Surgery:

  • The 2022 WSES guidelines 6 cite a systematic review and meta-analysis of 1,120 emergency general surgery patients from 7 studies examining hand-sewn versus stapled anastomoses, reporting on anastomotic failure, abscess formation, fistula, duration of hospital stays, and mortality—outcomes that overlap with your planned study.

Critical Overlap with Your Planned Study

Your planned network meta-analysis faces significant redundancy concerns:

  • Anastomotic leak rates: Already extensively meta-analyzed across multiple populations (Crohn's disease, rectal cancer, emergency surgery, general colorectal surgery) 6, 1, 3, 4, 5, 2

  • Hospital length of stay: Specifically included as an outcome in multiple existing meta-analyses 1, 4, 5, 2

  • Multiple technique comparisons: Network meta-analysis methodology has already been applied to this question 1, 3

  • Exclusion of adhesion outcomes: This exclusion criterion does not differentiate your study, as most existing meta-analyses already focus on leak rates and hospital stay without emphasizing adhesions

Methodological Considerations

The existing literature reveals important patterns:

Quality concerns across all meta-analyses:

  • The 2024 ECCO guideline 1 explicitly notes that "the quality of the studies included in systematic reviews and meta-analyses was notably limited, with only a minority of patients participating in RCTs and heterogeneous populations studied"

  • The 2026 meta-analysis 4 acknowledges that "limited numerical reporting in the source studies restricted full quantitative synthesis"

  • The 2026 rectal cancer network meta-analysis 3 concluded with "low certainty of evidence"

Heterogeneity remains problematic:

  • Study populations vary widely (elective vs. emergency, Crohn's disease vs. cancer, trauma vs. non-trauma) 6, 1, 4
  • Anastomotic configurations are inconsistently defined across studies 1, 2
  • The 2022 WSES guidelines 6 note that "patient selection and operator surgical skills bias all retrospective studies, which cannot be corrected even by the most advanced statistical methods"

Recommendation for Your Planned Study

Before proceeding, conduct a comprehensive search of PROSPERO (International Prospective Register of Systematic Reviews) to identify any ongoing meta-analyses with identical scope. The evidence demonstrates that your planned study's core outcomes—anastomotic leak rates and hospital length of stay comparing colorectal anastomotic techniques—have been extensively meta-analyzed already 6, 1, 3, 4, 5, 2.

To justify a new meta-analysis, you would need to:

  • Identify a specific population gap not addressed by existing reviews (e.g., a particular age group, comorbidity profile, or surgical indication)
  • Apply novel methodological approaches that address the quality and heterogeneity concerns identified in existing meta-analyses
  • Focus on recently published primary studies (post-2024) not included in the most recent meta-analyses
  • Provide a compelling rationale for why another synthesis would change clinical practice beyond what existing meta-analyses have already concluded

The 2024 ECCO guideline 1 and 2026 studies 3, 4, 5 represent the most current syntheses of this evidence, and any new meta-analysis would need to demonstrate clear added value beyond these comprehensive reviews.

Related Questions

What is an appropriate refined title for a network meta‑analysis of surgical techniques for colorectal anastomosis evaluating anastomotic leak rate and hospital length of stay, excluding adhesion outcomes?
How can I verify that no prior network meta‑analysis has compared the five elective colon cancer resection anastomotic techniques (side‑to‑side, end‑to‑end, hand‑sewn, Barcelona technique, functional end‑to‑end) for outcomes such as anastomotic leak rate, length of stay, and postoperative complications, to avoid duplicating existing research?
Is it feasible to conduct a network meta‑analysis of anastomotic reinforcement techniques (hand‑sewn, stapled, and compression‑ring devices) in elective left‑sided colon cancer resections, and what would be an appropriate title for such a study?
Could you propose a network meta‑analysis comparing side‑to‑side, end‑to‑end, end‑to‑side hand‑sewn, Barcelona‑technique stapled, and functional end‑to‑end anastomotic techniques for adult patients undergoing elective colon cancer resection, using anastomotic leak rate, postoperative hospital length of stay, and related postoperative outcomes as endpoints?
In adult patients undergoing elective curative left- or right‑sided colon resection (excluding trauma, inflammatory bowel disease, emergency presentation, obstruction, perforation, and rectal cancer), which anastomotic technique—hand‑sewn, linear stapled, circular stapled, or intracorporeal versus extracorporeal—produces the lowest anastomotic leak rate, shortest postoperative hospital stay, fewest postoperative complications, and shortest operative duration?
What is an appropriate refined title for a network meta‑analysis of surgical techniques for colorectal anastomosis evaluating anastomotic leak rate and hospital length of stay, excluding adhesion outcomes?
What are the indications for mupirocin?
For a type 2 diabetic adult receiving liposomal amphotericin B, can normal saline be used to dilute the medication, and if not, which diluent should be used, what volume of diluent and drug mixture (mL), what infusion rate (mL per hour), and how often should it be administered?
What can be given to treat restless legs syndrome in a patient receiving vancomycin, gabapentin, and a fentanyl patch?
Is it healthy for a healthy 27‑year‑old woman who avoids red meat and consumes three egg yolks daily?
Is it safe for a healthy adult with no personal or family history of high cholesterol, heart disease, diabetes, or metabolic disorders, and with normal lipid panel results, to consume three whole eggs per day?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.